Oncology

The new guidance introduces pivotal updates that help better refine diagnostic and therapeutic workflows. It also emphasizes an environment of highly individualized, technology-supported, and preventive diabetes care.

The drug targets a mutation found in more than 90% of pancreatic cancers.

New screening guidelines say cell-free DNA-based blood test is an option for patients who decline stool-based or visual screening tests.

‘While not curing the cancer, it is a very large step forward,’ said Dr. Zev Wainberg, of the University of California, Los Angeles, who helped lead the study.

Get the info you need on this new product, part of our drug news roundup for June.

The field of cell and gene therapies is a fascinating and complex area of drug development that has led to breakthroughs in the treatment of several types of cancer and some rare genetic disorders.

The clinic’s goal is to centralize decision-making so patients no longer have to co-ordinate their own care while coping with cancer and pregnancy simultaneously.

The patient records included in the study cover more than 60 years of colorectal cancer screening.